课题基金 / 基金详情

项目摘要

项目成果

Anna Greka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The canonical transient receptor potential channel 6 (TRPC6) has been recently added to the growing number of genes involved in familial forms of proteinuric kidney disease, characterized by nephrosis and ultimate renal failure. Interestingly, all TRPC6 mutations known to date are gain of function mutations, suggesting that increased Ca+2 influx through TRPC6 channels leads to podocyte injury. The mechanisms for TRPC channel regulation in podocytes are largely unknown. Furthermore, the question remains whether an increase in Ca+2 influx through TRPC channels occurs in both genetic and acquired forms of proteinuric kidney disease. Our preliminary data suggest that TRPC1 and TRPC5 are expressed in glomerular podocytes, where, like TRPC6, they localize to podocyte foot processes, in the vicinity of slit diaphragms. Our adhesion assays and wound assays in podocytes demonstrate a striking translocation of channel to membrane ruffles, indicating that channel localization is a regulated process. Angiotensin induces prominent calcium transients in podocytes expressing the AT1R, and a significant portion of this calcium influx appears to be mediated by TRPC channels. Patch clamp experiments in podocytes confirm the presence of a TRPC-like current. Single channel recordings suggest that channel activity is regulated by channel translocation to the membrane. When membrane trafficking is disrupted by pharmacologic and molecular techniques in podocytes, the TRPC-like current is largely diminished, supporting the notion that channel activity is regulated by channel translocation to the membrane. Based on our preliminary work, we hypothesize that TRPC1 and TRPC5 form novel channels in podocytes, which, in concert with TRPC6, mediate Ca+2 influx by their regulated translocation to the plasma membrane in response to upstream signaling through the Angiotensin Type 1 Receptor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of TRPC5 channel inhibition in the treatment of glomerular disease
  • 批准号:
    8760609
  • 项目类别:
  • 资助金额:
    $36.52万
  • 财政年份:
    2014
  • 负责人:
    Anna Greka
  • 依托单位:
Ion-channel targeted therapy for progressive kidney diseases
  • 批准号:
    10453797
  • 项目类别:
  • 资助金额:
    $38.48万
  • 财政年份:
    2014
  • 负责人:
    Anna Greka
  • 依托单位:
Role of TRPC5 channel inhibition in the treatment of glomerular disease
  • 批准号:
    8927620
  • 项目类别:
  • 资助金额:
    $36.61万
  • 财政年份:
    2014
  • 负责人:
    Anna Greka
  • 依托单位:
Ion-channel targeted therapy for progressive kidney diseases
  • 批准号:
    10216240
  • 项目类别:
  • 资助金额:
    $38.48万
  • 财政年份:
    2014
  • 负责人:
    Anna Greka
  • 依托单位:
海外基金